Reduction of nevirapine-driven HIV mutations by carbamazepine is modulated by CYP3A activity

D. Baranyai, E. Muro, U. Godtel-Armbrust, M.A. Schirmer, E. Kisanga, U. Diczfalusy, Q. Fillekes, R. Schuurman, D. Burger, L. Wojnowski

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1933-1937
Number of pages5
JournalJournal of Antimicrobial Chemotherapy
Volume69
Issue number7
Publication statusPublished - 2014

Cite this